Hunan pharmaceutical companies took more than 8 billion oral anti-sugar drugs, the original research drugs were again affected

Medicine Network January 22 - January 21, the Official Website of the State Drug Administration shows that Hunan Qianjin Xiangjiang Pharmaceutical's Akapo sugar tablets to copy 4 categories of products were approved, and as reviewed.
addition, his Dara non-film was also approved on the same day. in 2019, the total sales of Acapo sugar tablets in china's public medical institutions terminals and Chinese city physical pharmacies terminals exceeded 8 billion yuan, of which Bayer has the largest market share, according to
meters of intranet data.
the release of information on the drug approval documents to be received on January 21, 2021, Akapo sugar tablets are suitable for the treatment of type 2 diabetes, as well as for reducing after-dinner blood sugar in people with low sugar tolerance, the product was originally developed by Bayer. according to
meters of intranet data, in 2019 in China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminals and China's urban physical pharmacies terminal a capable of sales of more than 8 billion yuan, of which Bayer has the largest market share, in China's public medical institutions accounted for more than 55% of terminals, in China's urban physical pharmacies terminal accounted for more than 80%.
source: MED2.0 China Drug Review Database Up to now, Acapo sugar tablet manufacturers have Bayer, Hangzhou Sino-American East China Pharmaceuticals, Stone Pharmaceutical Group, such as 8. in terms of
consistency evaluation, Hangzhou Sino-American East China Pharmaceuticals was approved for supplementary applications, Zhejiang Haizheng Pharmaceuticals, Stone Pharmaceutical Group Euro-Italian Pharmaceuticals, Beijing Fuyuan Pharmaceuticals, Hunan Qianjin Xiangjiang Pharmaceuticals, Beijing BokangJian genes were approved in 4 categories of imitation, as reviewed.
addition, there are China Resources Seko Pharmaceuticals, Shandong Lu Anti-Pharmaceuticals, Chongqing Pharmaceutical Friends Pharmaceuticals and other more than 10 enterprises to copy 4 categories of applications submitted for listing in the review and approval (in the drug review center).
source: the official website of the Drug Administration, the Mienet database